Global Tumor-on-a-chip Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Latest Trends
Publisher : MRA | Format : PDF
Global Tumor-on-a-chip Market Research Report 2024
According to MRA Research’s new survey, global Tumor-on-a-chip market is projected to reach US$ 69 million in 2033, increasing from US$ 8 million in 2023, with the CAGR of 32.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Tumor-on-a-chip market research.
The global Organ-on-a-chip market is valued at 21.09 million US$ in 2018. The market share will reach 219.00 million US$ by the end of 2025, growing at a CAGR of 39.90% during 2019-2025.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Tumor-on-a-chip market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Cellesce
Daxiang Biotech
Mimetas
InSphero
Hepregen
Charles River
Segment by Type
PDX Model
CDX Model
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Tumor-on-a-chip report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
The global Organ-on-a-chip market is valued at 21.09 million US$ in 2018. The market share will reach 219.00 million US$ by the end of 2025, growing at a CAGR of 39.90% during 2019-2025.
Report Scope
This report, based on historical analysis (2018-2023) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Tumor-on-a-chip market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Cellesce
Daxiang Biotech
Mimetas
InSphero
Hepregen
Charles River
Segment by Type
PDX Model
CDX Model
Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Tumor-on-a-chip report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source